Litigation Details for SHIRE LLC v. AMERIGEN PHARMACEUTICALS LIMITED (D.N.J. 2014)

✉ Email this page to a colleague

Docket	⤷ Try a Trial	Date Filed	2014-10-01
Court	District Court, D. New Jersey	Date Terminated	2017-03-02
Cause	35:271 Patent Infringement	Assigned To	Renee Marie Bumb
Jury Demand	None	Referred To	Magistrate Judge Joel Schneide
Patents	6,322,819; 6,605,300; RE41,148; RE42,096
Link to Docket	External link to docket

The small molecule drugs covered by the patents cited in this case are ⤷ Try a Trial and ⤷ Try a Trial .

Subscribe to access the full database, or Try a Trial
Date Filed	Document No.	Description	Snippet	Link To Document
2014-10-01	1		System,” is a reissue of U.S. Patent. No. 6,322,819 (“the ’819 Patent”), which issued on November 27,…States Reissued Patent Nos. RE42,096 (“the ’096 Patent”) and RE41,148 (“the ’148 Patent”). Shire seeks… 1. This action for patent infringement, brought pursuant to the patent laws of the United States…. This civil action for patent infringement arises under the patent laws of the United States, including…’096 and ’148 Patents encompass ADDERALL XR®. 8. The ’096 Patent, entitled “Oral	External link to document
2017-02-06	251		to Preclude Assertion of Claim 25 of U.S. Patent No. RE42,096 by AMERIGEN PHARMACEUTICALS LIMITED. (Attachments…2014 2 March 2017 1:14-cv-06095-RMB-JS Patent None District Court, D. New Jersey	External link to document
2017-02-06	252		to Preclude Assertion of Claim 25 of U.S. Patent No. RE42,096 (CONFOY, KAREN)NOTICE TO COUNSEL: Counsel…2014 2 March 2017 1:14-cv-06095-RMB-JS Patent None District Court, D. New Jersey	External link to document
2017-02-13	263		to Preclude Assertion of Claim 25 of U.S. Patent No. RE42,096 (Attachments: # 1 Declaration of Miles Galbraith…2014 2 March 2017 1:14-cv-06095-RMB-JS Patent None District Court, D. New Jersey	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document